Blue Biofuels (BIOF) 10-Q 13 Nov 23 2023 Q3 Quarterly report Financial data

Cover

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 10, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-54942
Entity Registrant Name	BLUE BIOFUELS, INC.
Entity Central Index Key	0001549145
Entity Tax Identification Number	45-4944960
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	3710 Buckeye Street
Entity Address, Address Line Two	Suite 120
Entity Address, City or Town	Palm Beach Gardens
Entity Address, State or Province	FL
Entity Address, Postal Zip Code	33410
City Area Code	(888)
Local Phone Number	607-3555
Title of 12(b) Security	Common Stock par value $0.001
Trading Symbol	BIOF
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		302,750,963

Condensed Balance Sheets (Unaud

Condensed Balance Sheets (Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets
Cash and cash equivalents	$ 84,663	$ 211,901
Grants receivable	130,835
Prepaid expenses	38,209	43,119
TOTAL CURRENT ASSETS	253,707	255,020
Long-term assets
Property and equipment, net of accumulated depreciation and amortization of $214,125 and $127,178 at September 30, 2023 and December 31,2022, respectively	612,258	420,115
Security deposits	30,276	30,276
Right of Use Assets, net of accumulated amortization	105,418	178,399
Patents	247,854	222,109
TOTAL LONG-TERM ASSETS	995,806	850,899
TOTAL ASSETS	1,249,513	1,105,919
Current liabilities
Lease Liability - Current	101,905	95,172
Chapter 11 Settlement		50,000
Interest Payable - Related Party	120,124	76,138
TOTAL CURRENT LIABILITIES	1,319,991	638,721
Long term liabilities
Right of Use Lease Liability, net of current portion	8,793	85,983
Notes Payable — Other	216,570	216,570
TOTAL LONG TERM LIABILITIES	3,021,925	2,824,115
TOTAL LIABILITIES	4,341,916	3,462,836
STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred stock; $0.001 par value; 10,000,000 shares authorized; zero shares issued and outstanding
Common stock; $0.001 par value; 1,000,000,000 shares authorized; 302,750,963 issued and outstanding at September 30, 2023, and 289,941,623 shares issued and outstanding at December 31, 2022.	302,751	289,942
Additional paid-in capital	51,936,716	50,134,727
Accumulated deficit	(55,331,869)	(52,781,586)
Total stockholders’ equity (deficit)	(3,092,403)	(2,356,917)
TOTAL EQUITY (DEFICIT)	(3,092,403)	(2,356,917)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT	1,249,513	1,105,919
Nonrelated Party [Member]
Current liabilities
Accounts payable	698	37,135
Related Party [Member]
Current liabilities
Accounts payable	72,670	72,670
Deferred wages and director’s fees - Related party	674,594	307,606
Convertible Notes Payable — Related Party	350,000
Long term liabilities
Notes Payable — Related Party	$ 2,796,562	$ 2,521,562

Condensed Balance Sheets (Una_2

Condensed Balance Sheets (Unaudited) (Parenthetical) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Accumulated depreciation and amortization on property and equipment	$ 214,125	$ 127,178
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,000,000,000	1,000,000,000
Common stock, shares issued	302,750,963	289,941,623
Common stock, shares outstanding	302,750,963	289,941,623

Consolidated Statement of Opera

Consolidated Statement of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Related Party Transaction [Line Items]
Revenues
Operating expense:
General and administrative	219,160	178,512	943,953	1,223,083
Research & Development	293,674	404,157	1,741,318	2,070,789
Loss on disposal of assets			369	40,099
Total operating expenses	512,834	582,669	2,685,640	3,333,971
Loss from operations:	(512,834)	(582,669)	(2,685,640)	(3,333,971)
Other (income) expense:
Interest expense - other	2,443	29,313	7,431	30,934
Total other (income) expense	(180,839)	36,024	(135,357)	51,069
Income (Loss) before provisions for income taxes	(331,995)	(618,693)	(2,550,283)	(3,385,040)
Provisions for income taxes
Net Income / (Loss):	$ (331,995)	$ (618,693)	$ (2,550,283)	$ (3,385,040)
Net income (loss) per share	$ (0.001)	$ (0.002)	$ (0.008)	$ (0.012)
Basic and Diluted Earnings per share	$ (0.001)	$ (0.002)	$ (0.008)	$ (0.012)
Weighted average common shares outstanding - Basic	302,750,963	277,416,282	302,750,963	277,416,282
Weighted average common shares outstanding - Fully Diluted	302,750,963	277,416,282	302,750,963	277,416,282
Related Party [Member]
Other (income) expense:
Grants received	$ (206,500)		$ (206,500)
Interest expense - related party	$ 23,218	$ 6,711	$ 63,712	$ 20,135

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($)	Common Stock [Member]	Preferred Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Balance at Dec. 31, 2021	$ 274,004		$ 47,151,353	$ (48,821,403)	$ (1,396,046)
Balance, shares at Dec. 31, 2021	274,003,883
Issuance of common stock for services	$ 448		70,852		71,300
Issuance of common stock for services, shares	447,781
Vesting of options under the employee, director plan			1,316,277		1,316,277
Net Income (Loss)				(2,040,957)	(2,040,957)
Employee stock options exercised	$ 150		7,350		7,500
Employee stock options exercised, shares	150,000
Balance at Mar. 31, 2022	$ 274,602		48,545,832	(50,862,360)	(2,041,926)
Balance, shares at Mar. 31, 2022	274,601,664
Balance at Dec. 31, 2021	$ 274,004		47,151,353	(48,821,403)	(1,396,046)
Balance, shares at Dec. 31, 2021	274,003,883
Net Income (Loss)					(3,385,040)
Balance at Sep. 30, 2022	$ 281,817		49,822,662	(52,206,443)	(2,101,964)
Balance, shares at Sep. 30, 2022	281,815,770
Balance at Mar. 31, 2022	$ 274,602		48,545,832	(50,862,360)	(2,041,926)
Balance, shares at Mar. 31, 2022	274,601,664
Issuance of common stock for services	$ 79		16,071		16,150
Issuance of common stock for services, shares	78,600
Issuance of common stock and warrants for cash through PPM	$ 4,500		670,500		675,000
Issuance of common stock and warrants for cash through PPM, shares	4,499,999
Vesting of options under the employee, director plan			99,106		99,106
Net Income (Loss)				(725,390)	(725,390)
Employee stock options exercised	$ 200		8,200		8,400
Employee stock options exercised, shares	200,000
Balance at Jun. 30, 2022	$ 279,380		49,339,710	(51,587,750)	(1,968,660)
Balance, shares at Jun. 30, 2022	279,380,263
Issuance of common stock for services	$ 169		28,981		29,150
Issuance of common stock for services, shares	168,842
Issuance of common stock and warrants for cash through PPM	$ 2,267		337,733		340,000
Issuance of common stock and warrants for cash through PPM, shares	2,266,665
Vesting of options under the employee, director plan			110,922		110,922
Net Income (Loss)				(618,693)	(618,693)
Issuance of warrants for services			5,317		5,317
Balance at Sep. 30, 2022	$ 281,817		49,822,662	(52,206,443)	(2,101,964)
Balance, shares at Sep. 30, 2022	281,815,770
Balance at Dec. 31, 2022	$ 289,942		50,134,727	(52,781,586)	(2,356,917)
Balance, shares at Dec. 31, 2022	289,941,623
Issuance of common stock for services	$ 140		23,860		24,000
Issuance of common stock for services, shares	140,000
Issuance of common stock and warrants for cash through PPM	$ 3,885		578,865		582,750
Issuance of common stock and warrants for cash through PPM, shares	3,884,998
Warrants exercised	$ 5,450		66,800		72,250
Warrants exercised, shares	5,450,148
Vesting of options under the employee, director plan			391,297		391,297
Net Income (Loss)				(1,064,090)	(1,064,090)
Balance at Mar. 31, 2023	$ 299,417		51,195,549	(53,845,676)	(2,350,710)
Balance, shares at Mar. 31, 2023	299,416,769
Balance at Dec. 31, 2022	$ 289,942		50,134,727	(52,781,586)	(2,356,917)
Balance, shares at Dec. 31, 2022	289,941,623
Issuance of common stock for services					$ 29,300
Issuance of common stock for services, shares					174,191
Issuance of common stock and warrants for cash through PPM					$ 1,002,772
Issuance of common stock and warrants for cash through PPM, shares					6,684,998
Warrants exercised					$ 97,250
Warrants exercised, shares					5,950,148
Net Income (Loss)					$ (2,550,283)
Balance at Sep. 30, 2023	$ 302,751		51,936,715	(55,331,870)	(3,092,403)
Balance, shares at Sep. 30, 2023	302,750,963
Balance at Mar. 31, 2023	$ 299,417		51,195,549	(53,845,676)	(2,350,710)
Balance, shares at Mar. 31, 2023	299,416,769
Issuance of common stock for services	$ 34		5,266		5,300
Issuance of common stock for services, shares	34,194
Issuance of common stock and warrants for cash through PPM	$ 633		94,389		95,022
Issuance of common stock and warrants for cash through PPM, shares	633,334
Warrants exercised	$ 500		24,500		25,000
Warrants exercised, shares	500,000
Vesting of options under the employee, director plan			245,732		245,732
Net Income (Loss)				(1,154,199)	(1,154,199)
Issuance of warrants for services			42,634		42,634
Balance at Jun. 30, 2023	$ 300,584		51,608,069	(54,999,875)	(3,091,221)
Balance, shares at Jun. 30, 2023	300,584,297
Issuance of common stock and warrants for cash through PPM	$ 2,167		322,833		325,000
Issuance of common stock and warrants for cash through PPM, shares	2,166,666
Net Income (Loss)				(331,995)	(331,995)
Issuance of warrants for services			5,813		5,813
Balance at Sep. 30, 2023	$ 302,751		$ 51,936,715	$ (55,331,870)	$ (3,092,403)
Balance, shares at Sep. 30, 2023	302,750,963

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) (Parenthetical) - shares	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023
Statement of Stockholders' Equity [Abstract]
Vesting of options previously issued under employee director plan		2,000,000	2,385,000	825,000	800,000	10,560,000	4,385,000
Warrants issued for services	50,000	314,000		37,333			364,000

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash flows from operating activities
Net Income (Loss)	$ (2,550,283)	$ (3,385,040)
Reconciliation of net loss to net cash used in operating activities
Depreciation and amortization	89,526	102,711
Stock based compensation for services	29,300	116,600
Net Issuance of options and warrants for services	685,474	1,531,622
Loss on Disposal of assets	369	40,099
Changes in operating assets and liabilities
Prepaid expenses	4,910	(41,729)
Grants receivable	(130,835)
Accrued interest - related party	43,986	20,135
Accounts payable and accrued liabilities	330,551	62,996
Right of use lease	2,525	(33,647)
Net cash used in operating activities	(1,494,477)	(1,586,253)
Cash flows from investing activities
Net Purchase of property and equipment	(282,038)	(61,800)
Patent Costs	(25,744)	(42,501)
Net cash from (used in) investing activities	(307,782)	(104,301)
Cash flows from financing activities
Proceeds from exercise of warrants and options	97,250	15,900
Net Proceeds from the issuance of Convertible Notes	625,000
Net proceeds from issuance of common stock	1,002,772	1,015,000
Payment of Debt	(50,000)
Net cash provided by financing activities	1,675,022	1,030,900
Net increase (decrease) in cash and cash equivalents	(127,237)	(659,653)
Cash and cash equivalent at beginning of the period	211,901	1,164,664
Cash and cash equivalent at end of the period	84,663	505,010
Cash paid during the period for
Interest
Taxes
Supplemental schedule of non-cash activities
Issuance of warrants for services	48,447	5,317
Issuance of common stock for services	29,300	116,600
Cashless conversion of warrants/options
Conversion of convertible debenture to common stock

ORGANIZATION

ORGANIZATION	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION	NOTE 1 – ORGANIZATION Blue Biofuels, Inc (the “Company”) is a technology company focused on emerging technologies in renewable energy, biofuels, and lignin. In early 2018, the Company’s chief executive officer (“CEO”) Ben Slager invented a new reactor technology with a higher yield and a continuous throughput in the Cellulose-to-Sugar process, or CTS, and the Company filed a process patent application for this technology. Mr. Slager has since further developed the system with the technical staff of the Company. The CTS patent was awarded in 2021 in the United States (U.S. Patent No. 10,994,255) and also in Japan and El Salvador. The Company also filed this patent in other major jurisdictions of the world including the European Patent Organization, Australia, Brazil, China, the African Regional Intellectual Property Organization, and the Russian Federation. The patent applications are currently pending in all of these international jurisdictions. In addition to this patent, the Company has received one additional patent (for which it has also applied in all the above-mentioned jurisdictions). Further, the company has filed for 4 other patents which are currently pending. Mr. Slager has since further developed the system with the technical staff of the Company. The patented CTS process is a continuous mechanical/chemical dry process for breaking down cellulosic material for conversion into biofuels. CTS can break down any cellulosic material – including grasses and agricultural waste. The CTS mechanical/chemical process allows for exact process control to ensure that all the material passing through it does so on the optimum reaction parameters through which optimal efficiency is achieved. The new technology made it worthwhile to financially restructure the Company through Chapter 11. The Company voluntarily filed for Chapter 11 on October 22, 2018, in the U.S. Bankruptcy Court in the Southern District of Florida. The Company exited Chapter 11 on September 18, 2019, while keeping all classes, including shareholders, unimpaired. The bankruptcy case was closed on October 25, 2019. CTS is environmentally friendly in that it recycles the water and catalyst, and it has a low carbon footprint: the amount of added atmospheric carbon created by burning the biofuels produced by the CTS system was absorbed by the plant-based feedstock while growing and is merely released back into the atmosphere. No extra CO2 is released into the atmosphere when our biofuels are burned. This is to be distinguished from fossil fuels because new CO2 is released when fossil fuels are burned. The Company believes a significant difference between CTS cellulosic ethanol and corn ethanol is the wide range of abundantly available feedstocks that CTS can process compared to just corn as the feedstock. The CTS feedstocks are nonfood and have much lower costs than corn. In addition, while in corn ethanol only the corn kernels are used, CTS uses the whole plant or its waste products, meaning it could obtain much higher yields per acre. In 2022, the Company partnered with K.R. Komarek to build its CTS machines going forward. Komarek is an industry leading manufacturing company that builds briquetting machines and compaction/granulation systems with throughput capacities up to 50 tons per hour. In 2023, the Company completed the build-out of a pilot plant based on a modified Komarek machine and is in the process of further testing and optimizing the plant. The Company believes that it can optimize the pre and post processing elements at this pilot scale plant to finalize design and operational parameters to provide operating cost estimates of a full-scale commercial volume system. Due to its mechanical nature and modularity, we anticipate that one plant would have multiple modular CTS systems. In addition, the Company has licensed the Vertimass Process to convert ethanol into sustainable aviation fuel (SAF) and other renewable biofuels including bio-gasoline. The license agreement with Vertimass is the subject to a confidentiality agreement between the parties. Plan of Operation The total process from cellulosic feedstock to SAF consists basically of three steps: 1) Conversion from feedstock to fermentable cellulosic sugars (CTS) 2) Ferment the cellulosic sugars into cellulosic ethanol. 3) Covert the ethanol into SAF and related products. This third step happens with the Vertimass technology which the Company has licensed. Given the fact that the Vertimass technology is mature and ready for production, the Company is reviewing whether to start executing on SAF production on a 10 million gallon per year level, and then add the first two steps on to it in a later phase when CTS is fully commercialized. The Company intends to build commercial CTS and ethanol facilities on the front-end to produce cellulosic SAF and generate the large D7 RIN and other government credits Any new biofuels plant that is built would require various government permits. In particular, renewable fuels are subject to rigorous testing and premarket approval requirements by the EPA’s Office of Transportation and Air Quality and regulatory authorities in other countries. In the U.S., various federal, and, in some cases, state statutes and regulations also govern or impact the manufacturing, safety, storage and use of renewable fuels. The process of seeking required approvals and the continuing need for compliance with applicable statutes and regulations requires the expenditure of resources. The Company anticipates raising the necessary capital for this as a part of its project-based financing. The ethanol industry is competitive with over 200 ethanol plants in the United States alone. Currently, the vast majority use corn as feedstock. Their profitability depends highly on the fluctuations between the price of corn and the price of ethanol. Since the Company does not plan to use corn, and plans on having long-term purchase agreements with cellulosic feedstock suppliers, we anticipate that our profitability will be more consistent. Further, cellulosic biofuels yield much higher incentives than non-cellulosic biofuels. The Energy Policy Act of 2005, which included the Renewable Fuel Standard Program enforced by the US Environmental Protection Agency (EPA), mandates a certain amount of renewable fuel be blended into the transportation fuel used by all vehicles in the country. This Program provides monetary incentives to companies that produce renewable transportation fuel, and establishes Renewable Identification Numbers (RINs) or credits for each gallon of renewable transportation fuel produced in the United States, and breaks down those fuels into different D-codes depending on the source of the renewable fuel. D3 is the code for renewable ethanol that comes from cellulosic materials. The EPA’s final D3 RIN volume mandates for cellulosic biofuel include 840 million gallons for 2023, 1.09 billion gallons for 2024, and 1.38 billion gallons for 2025 (the D3 mandate). This mandate has increased every year and is statutorily mandated to increase in the future and become a larger portion of the full renewable fuels mandate, if and when cellulosic biofuels can be produced profitably in larger and larger quantities. The RFS mandate for 2023 calls for 20.94 billion gallons of total renewable fuel, 15 billion from conventional biofuels (corn ethanol) and 5.94 billion from advanced biofuels, including cellulosic biofuels. The “blend wall” (or upper limit to the amount of ethanol that can be blended into U.S. gasoline and automobile performance and comply with the Clean Air Act) of limiting ethanol content in gasoline to 10%, limits the total amount of ethanol consumed in the United States. Recent proposals have make 15% blending available year around in some states. The value of the D3 RIN fluctuates, but as of this filing, it is approximately $3.53 per gallon of ethanol. For comparison, the D6 RIN for corn ethanol is $0.79. To profit from these incentives, the Company plans to apply for these D3 RIN credits as it brings its first plant into commercial operation. Section 45Z of the Inflation Reduction Act passed on August 16, 2022, offers a Clean Fuel Production Credit (CFPC) per gallon of transportation fuel produced with a base amount of 20 cents per gallon or up to $1 per gallon for a qualified facility (depending on its carbon index) that was built while paying at least prevailing wages and which met apprenticeship requirements. For sustainable aviation fuel, those figures are 35 cents and $1.75 per gallon respectively. The Company plans to apply for CFPC credits when it begins building its commercial facilities. The CFPC currently does not apply to transportation fuel sold after December 31, 2027. A Low Carbon Fuel Standard Credit (LCFS) is offered by various states (primarily California) for any amount of reduced CO2 in the production lifecycle of transportation fuels as compared to the amount of CO2 emitted in the production lifecycle of fossil fuels. The production lifecycle includes transportation costs to the point of use. California is currently offering around $67.00 per metric ton of CO2 reduction. When it is closer to commercial production, the Company plans to analyze the cost effectiveness of applying for these LCFS credits to determine in which state it could earn the most credits. At commercial scale, management expects to be able to earn substantial renewable fuel credits and produce sustainable ethanol, sustainable aviation fuel, and other sustainable biofuels more profitably than they could be from existing commercial corn ethanol producers. Cellulosic ethanol comes with a much more valuable D3 RIN credit as compared to the D6 RIN allocated to corn ethanol; cellulosic SAF comes with a very valuable D7 RIN, and cellulosic bio-gasoline comes with a valuable D3 RIN. The Company also expects to receive Clean Fuel Production Credits related to section 45Z of the Inflation Reduction Act, whereas these credits are so far not available for corn ethanol producers; and the Company also plans to pursue Low Carbon Fuel Standard Credits. After its first plant is profitable, the Company intends to grow with additional plants in the United States and explore international growth by either licensing the CTS technology or forming joint ventures with foreign domestic partners to build plants. The Company believes that its management and consultants have significant experience in the development of technologies from concept to commercialization. As of this date, the Company has not generated any material revenues from its business.

GOING CONCERN

GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared in conformity with generally accepted accounting principles, which contemplate continuation of the Company as a going concern, which assumes the Company will realize its assets and discharge its liabilities in the normal course of business. The Company has not generated any significant revenue since inception and has incurred losses since inception. As of September 30, 2023, the Company has incurred accumulated losses of $ 55,331,869 Management believes that the Company’s future success is dependent upon its ability to achieve profitable operations, generate cash from operating activities, and obtain additional financing. There is no assurance that the Company will be able to generate sufficient cash from operations, or sell additional shares of stock or borrow additional funds. The Company’s inability to obtain additional cash could have a material adverse effect on its financial position, results of operations, and its ability to continue in existence. These financial statements do not include any adjustments that might result from the outcome of this uncertainty. The COVID-19 pandemic has negatively affected the U.S. and global economies, disrupted global supply chains, resulted in significant travel and transport restrictions, including mandated closures and orders to “shelter-in-place,” and created significant disruption of the financial markets. We are closely monitoring the impact of the COVID-19 pandemic on all aspects of our business, including how it will impact our supply chain, employees, and potential future customers. Our office and lab have remained open during the pandemic. Nevertheless, the pandemic slowed our ability to commercialize our process in two ways: by adversely affecting our ability to raise capital, and by adversely affecting the supply chain of laboratory equipment and various parts of upgrades to our CTS system, which slowed the development of our prototypes. Supply chain issues also delayed the delivery of various parts of our pilot plant. The extent to which our operations may be further impacted by the COVID-19 pandemic will depend largely on future developments, which are highly uncertain and cannot be accurately predicted. We may experience additional operating costs due to increased challenges with our workforce (including as a result of illness, absenteeism or government orders), access to supplies, capital, and fundamental support services (such as shipping and transportation). Even after the COVID-19 pandemic has subsided, we may experience materially adverse impacts to our business due to any resulting economic recession or depression. Furthermore, the effects of a potential worsening of global economic conditions and the continued disruptions to and volatility in the financial markets remain unknown.

SUMMARY OF SIGNIFICANT ACCOUNTI

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control. Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates. Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents. Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance. Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the nine months ended September 30, 2023, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the nine months ended September 30, 2023: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 2/10/23 2/14/23 3/1/23 3/31/23 4/5/23 4/11/23 Risk-free interest rate 3.93 % 3.77 % 4.01 % 3.60 % 3.30 % 3.54 % Expected life 5 10 10 5 10 5 Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 123.25 % 123.26 % 123.52 % 120.71 % 119.51 % 119.39 % BIOF common stock fair value $ 0.159 $ 0.159 $ 0.177 $ 0.166 $ 0.154 $ 0.145 4/26/23 6/5/23 7/13/23 7/26/23 Risk-free interest rate 3.46 % 3.77 % 3.93 % 3.86 % Expected life 5 7 5 10 Expected dividends 0 % 0 % 0 % 0 % Expected volatility 119.28 % 103.20 % 90.70 % 87.22 % BIOF common stock fair value $ 0.165 $ 0.170 $ 0.160 $ 0.160 Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 10 Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol of the CTS process), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process, which were $ 247,854 222,109 Research and Development The Company expenses all research and development costs as incurred. For the nine months ended September 30, 2023, and September 30, 2022, the amounts charged to research and development expenses were $ 1,741,318 2,070,789 Revenue Recognition The Company follows FASB ASC 606 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured. Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required. Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell. Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented. Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions) Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

PROPERTY AND EQUIPMENT

PROPERTY AND EQUIPMENT	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
PROPERTY AND EQUIPMENT	NOTE 4 – PROPERTY AND EQUIPMENT SCHEDULE OF PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT Life September 30, 2023 December 31, 2022 Building and Improvements 15 $ 9,370 $ 9,370 Machinery and Equipment 10 $ 791,540 $ 512,450 Furniture and Fixtures 5 $ 13,649 $ 13,649 Computer Equipment 3 $ 11,824 $ 11,824 Property and Equipment, gross $ 826,383 $ 547,293 Less Accumulated Depreciation $ (214,125 ) $ (127,178 ) Property and Equipment $ 612,258 $ 420,115 Total depreciation expense was $ 89,526 In the nine months ended September 30, 2023, The Company purchased machinery worth $ 285,538 3,500 6,448 2,579 369

PATENTS

PATENTS	9 Months Ended
	Sep. 30, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
PATENTS	NOTE 5 – PATENTS The Company has been granted one patent on its technology and one continuation patent, has filed for three others that are pending, and has also applied for international patents. The Company has capitalized the legal and filing fees in the amount of $ 247,854

DEBT

DEBT	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
DEBT	NOTE 6 – DEBT Notes Payable – Related Parties On August 10, 2023, the Company entered into a long-term convertible note with board member Chris Kneppers, with a principal balance of $ 50,000 10 The Note is convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a 5 333,333 In July 2023, the Company entered into a long-term convertible note with board member Edmund Burke, with a principal balance of $ 25,000 accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 50,000 every 12 months instead of interest, with a minimum of 50,000 warrants 0.13 192,308 In June 2023, the Company entered into a long-term convertible note with board member Chris Kneppers, with a principal balance of $ 50,000 10 The Note is convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a 5 333,333 In June 2023, the Company entered into a short-term convertible note with board member Chris Kneppers, with a principal balance of $ 100,000 0.13 769,231 In April 2023, the Company entered into a long-term convertible note with board member Edmund Burke, with a principal balance of $ 150,000 accrued warrants, with a strike price of 15 cents and an expiration of 5 0.13 1,153,846 In January 2023, the Company entered into a short-term convertible note with board member Chris Kneppers, with a principal balance of $ 250,000 0.13 1,923,077 In July 2016, the Company issued six (6) short-term notes payable to related parties in conjunction with the Company’s acquisition of the remaining 49% of AMG Energy Group. These notes had a value of $2,002,126 and accrued interest at a rate of six percent ( 6 The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019. 240,990 579,942 1.5 On February 28, 2018, the Company entered into a short-term loan with Steven Sadaka, with a principal balance of $ 100,000 May 1, 2018 2,000,000 84,000 100,000 On May 15, 2018, the Company entered into a short-term loan with Christopher Jemapete, with a principal balance of $ 50,000 May 16, 2019 5 1,250,000 36,250 315 50,315.07 On May 15, 2018, the Company entered into a short-term loan with Pamela Jemapete, with a principal balance of $ 50,000 May 16, 2019 5 1,250,000 36,250 315 50,315.07 Notes Payable – Other In July 2016, the Company issued a short-term note payable to a third party in conjunction with the Company’s acquisition of the remaining 49 96,570 6 The Company renegotiated this note during its Chapter 11 proceedings, and as per the Plan Confirmation, now the $ 96,570 In November 2017, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $ 143,000 May 30, 2018 8 43,000 35 500,000 39,500 40,000 100,000 5 In February 2018, the Company entered into a convertible debenture with Lucas Hoppel, with a principal balance of $ 165,000 September 21, 2018 8 15,000 40 500,000 14,500 100,000 5 On March 27, 2019, the Company entered into an agreement with another creditor, such that its debt will be reduced from $ 32,000 20,000 A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable September 30, 2023 December 31, 2022 Short Term Convertible Note – Related Party, including interest $ 371,908 $ 0 Short Term Chapter 11 Settlement $ 0 $ 50,000 Long Term Notes Payable after capital investment, incl interest $ 276,944 $ 0 Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 TOTAL NOTES $ 3,386,984 $ 2,788,132 Of the $ 3,386,984 2,738,132 275,000 2,417,502 2,738,132 969,482 849,482 120,000

STOCKHOLDERS_ EQUITY

STOCKHOLDERS’ EQUITY	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ EQUITY	NOTE 7 – STOCKHOLDERS’ EQUITY The total number of shares of capital stock, which the Company has authority to issue, is 1,010 1 0.001 10 0.001 302,750,963 no For the nine months ended September 30, 2023, the Company issued an aggregate of 174,191 29,300 For the nine months ended September 30, 2023, 364,000 48,447 For the nine months ended September 30, 2023, 6,684,998 1,002,772 For the nine months ended September 30, 2023, 5,950,148 97,250 For the nine months ended September 30, 2023, 2,067,999 For the nine months ended September 30, 2023, 7,050,000 125,000 For the nine months ended September 30, 2023, 4,385,000 637,028 For the nine months ended September 30, 2023, 17,150,000 2,835,613

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 8 - COMMITMENTS AND CONTINGENCIES Litigation The Company is subject, from time to time, to litigation, claims and suits arising in the ordinary course of business. The Company is not in any litigation at this time. Cybersecurity No material cybersecurity breach has occurred. Leases The Company currently leases office and laboratory space in Palm Beach Gardens, FL, that is classified as operating lease right-of-use (“ROU”) assets and operating lease liabilities in the Company’s consolidated balance sheet. ROU assets and lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term at the commencement date for leases exceeding 12 months. The lease period was for twenty-four (24) months from November 1, 2019, to October 31, 2021. This had been extended for one year until October 31, 2022, and was further extended for two more years until October 31, 2024 84,100 3 102,950 3 3,600 ASC 842 was effective for us beginning January 1, 2019. The adoption had a material impact on our consolidated balance sheets, but did not have a material impact on our consolidated income statements. The most significant impact was the recognition of ROU assets and lease liabilities for operating leases. In addition, the Company leases land in Arcadia, FL where it grows king grass. The original lease began on September 1, 2020, and was for 18.2 6,370 5 167.6 24,721 5 Rent expense for the nine months ending September 30, 2023, and 2022, were $ 183,537 106,631 The Company recognized the following related to leases in its Consolidated Balance Sheet: SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET PERIOD ENDED September 30, 2023 December 31, 2022 Right of Use Lease Liabilities Current portion 101,905 95,172 Long-term portion 8,793 85,983 TOTAL 110,698 181,155 As of September 30, 2023, the total future minimum lease payments in respect of leased premises are as follows: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS YEAR ENDED MINIMUM DUE 2023 24,715 2024 85,983 2025 0 TOTAL $ 110,698

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 9 – RELATED PARTY TRANSACTIONS Related Party Transactions The Company follows FASB ASC subtopic 850-10, Related Party Disclosures, for the identification of related parties and disclosure of related party transactions. Pursuant to ASC 850-10-20, related parties include: a) affiliates of the Company; b) entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c) trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d) principal owners of the Company; e) management of the Company; f) other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g) other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests. 1) Short-term notes payable, convertible notes, and contingent liabilities issued to related parties are described in NOTE 6. 2) A board resolution was passed on February 13, 2020, that pledged the patents and pending patents to secure the back pay claims of Ben Slager, CEO, Anthony Santelli, CFO, and Charles Sills, Director. This was done to ensure the continued involvement of management to build the Company while they receive less than full salaries. The officers and directors for the Company are involved in other business activities and may, in the future, become involved in other business opportunities. If a specific business opportunity becomes available, such persons may face a conflict in selecting between the Company and their other business interest. The Company has not formulated a policy for the resolution of such conflicts.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 10 – SUBSEQUENT EVENTS The Company has evaluated subsequent events through the date the financial statements were issued. Based on this evaluation, the Company has identified the following subsequent events: From October 1, 2023, to the date of this filing, the Company issued 350,000 29,991 From October 1, 2023, to the date of this filing, the Company issued convertible notes to related parties for $ 15,000

SUMMARY OF SIGNIFICANT ACCOUN_2

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying consolidated financial statements of the Company were prepared in accordance with generally accepted accounting principles in the U.S. (“U.S. GAAP”) and include the assets, liabilities, revenues and expenses of the Company’s majority-owned subsidiaries over which the Company exercises control.
Principles of Consolidation	Principles of Consolidation The accompanying consolidated financial statements include the accounts of the Company and its subsidiaries, after elimination of intercompany accounts and transactions. Investments in business entities in which the Company lacks control but has the ability to exercise significant influence over operating and financial policies are accounted for using the equity method. All material intercompany transactions and balances were eliminated in consolidation.
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the dates presented and reported amounts of revenues and expenses during the reporting periods presented. Significant estimates inherent in the preparation of the accompanying Consolidated Financial Statements include estimates of impairment assessment of identifiable intangible assets and valuation allowance for deferred tax assets. Estimates are based on past experience and other considerations reasonable under the circumstances. Actual results may differ from these estimates.
Cash and Cash Equivalents	Cash and Cash Equivalents All highly liquid investments with maturities of three months or less at the date of purchase are considered to be cash equivalents.
Stock Compensation	Stock Compensation The Company recognizes the cost of all share-based payments under the relevant authoritative accounting guidance. Share-based payments include any remuneration paid by the Company in shares of the Company’s common stock or financial instruments that grant the recipient the right to acquire shares of the Company’s common stock. For share-based payments to employees, which consist only of awards made under the stock option plan described below, the Company accounts for the payments in accordance with the provisions of ASC Topic 718, “Stock Compensation” (formerly referred to as SFAS No. 123(R)). Share-based payments to consultants, service providers and other non-employees are accounted for in accordance with ASC Topic 718, ASC Topic 505, “Equity Payments to Non-Employees” or other applicable authoritative guidance.
Stock-based Compensation Valuation Methodology	Stock-based Compensation Valuation Methodology Stock-based compensation resulting from the issuance of common stock is calculated by reference to the valuation of the stock on the date of issuance, the expense being recognized as the compensation is earned. Stock-based compensation expenses related to employee options and warrants granted to non-employees are recognized as the stock options and warrants are earned. The fair value of the stock options or warrants granted is estimated at the grant date, using the Black-Scholes option-pricing model, and the expense is recognized on a straight-line basis over the shorter of the period over which services are to be received or the life of the option or warrant. The grant date fair value of employee share options and similar instruments is estimated using the Black-Scholes option-pricing model on the basis of the fair value of the underlying common stock on the measurement date, adjusted for the unique characteristics of those equity instruments, using the assumptions noted in the table below. The fair value of the common stock is determined by the then-prevailing closing market price. Expected volatility was based on the historical volatility of the Company’s closing day market price per share. The expected term of options and warrants was based upon the life of the option, and the risk-free rate used was based on the U.S. Treasury Daily Yield Curve Rate. The stock compensation issued for services during the nine months ended September 30, 2023, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the nine months ended September 30, 2023: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 2/10/23 2/14/23 3/1/23 3/31/23 4/5/23 4/11/23 Risk-free interest rate 3.93 % 3.77 % 4.01 % 3.60 % 3.30 % 3.54 % Expected life 5 10 10 5 10 5 Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 123.25 % 123.26 % 123.52 % 120.71 % 119.51 % 119.39 % BIOF common stock fair value $ 0.159 $ 0.159 $ 0.177 $ 0.166 $ 0.154 $ 0.145 4/26/23 6/5/23 7/13/23 7/26/23 Risk-free interest rate 3.46 % 3.77 % 3.93 % 3.86 % Expected life 5 7 5 10 Expected dividends 0 % 0 % 0 % 0 % Expected volatility 119.28 % 103.20 % 90.70 % 87.22 % BIOF common stock fair value $ 0.165 $ 0.170 $ 0.160 $ 0.160
Property and Equipment	Property and Equipment Property and equipment are stated at cost less accumulated depreciation. Depreciation is provided for on a straight-line basis over the useful lives of the assets, generally 5 10
Patent Capitalization	Patent Capitalization If a product is currently under research and development and is not currently approved for market, costs incurred in connection with patent applications should generally be expensed in the income statement because there is uncertainty as to the future economic benefit of the asset. Conversely, if a product is approved for market (as is the case of the end product ethanol of the CTS process), or if future economic benefit is probable, or if an alternative future use is available to the Company, then such patent costs can be capitalized and amortized over the expected life of the patent(s). Since the Company’s primary end product is sugar converting to ethanol, which are in wide use, the Company has determined that it is reasonable to capitalize the patent costs associated with its CTS process, which were $ 247,854 222,109
Research and Development	Research and Development The Company expenses all research and development costs as incurred. For the nine months ended September 30, 2023, and September 30, 2022, the amounts charged to research and development expenses were $ 1,741,318 2,070,789
Revenue Recognition	Revenue Recognition The Company follows FASB ASC 606 “Revenue Recognition” and recognizes revenue when it is realized or realizable and earned. The Company’s revenues will be derived principally from joint ventures, royalties and eventually corporate owned plants. However, no sales have occurred through those revenue streams to date. The Company considers revenue realized or realizable and earned when all of the following criteria are met: 1. persuasive evidence of an arrangement exists; 2. the product has been shipped or the services have been rendered to the customer; 3. the sales price is fixed or determinable; and, 4. collectability is reasonably assured.
Common Stock Purchase Warrants and Other Derivative Financial Instruments	Common Stock Purchase Warrants and Other Derivative Financial Instruments The Company classifies as equity any contracts that require physical settlement or net-share settlement or provide it with a choice of net-cash settlement or settlement in the Company’s own shares (physical settlement or net-share settlement) provided that such contracts are indexed to its own stock as defined in ASC 815-40 (“Contracts in Entity’s Own Equity”). The Company classifies as assets or liabilities any contracts that require net-cash settlement (including a requirement to net cash settle the contract if an event occurs and if that event is outside the Company’s control) or give the counterparty a choice of net-cash settlement or settlement in shares (physical settlement or net-share settlement). The Company assesses the classification of its common stock purchase warrants and other free-standing derivatives at each reporting date to determine whether a change in classification between assets and liabilities is required.
Impairment of Long-Lived Assets	Impairment of Long-Lived Assets Long-lived assets are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. If events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable, the Company compares the carrying amount of the asset group to future undiscounted net cash flows, excluding interest costs, expected to be generated by the asset group and their ultimate disposition. If the sum of the undiscounted cash flows is less than the carrying value, the impairment to be recognized is measured by the amount by which the carrying amount of the asset group exceeds the fair value of the asset group. Assets to be disposed of are reported at the lower of the carrying amount or fair value, less costs to sell.
Income Taxes	Income Taxes The Company uses the asset and liability method of accounting for income taxes in accordance with ASC Topic 740, “Income Taxes.” Under this method, income tax expense is recognized for the amount of: (i) taxes payable or refundable for the current year and (ii) deferred tax consequences of temporary differences resulting from matters that have been recognized in an entity’s financial statements or tax returns. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in the results of operations in the period that includes the enactment date. A valuation allowance is provided to reduce the deferred tax assets reported if based on the weight of the available positive and negative evidence, it is more likely than not some portion or all of the deferred tax assets will not be realized. ASC Topic 740.10.30 clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740.10.40 provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure, and transition. The Company has no material uncertain tax positions for any of the reporting periods presented.
Profit (Loss) per Common Share:	Profit (Loss) per Common Share: Basic profit (loss) per share amounts have been calculated using the weighted-average number of common shares outstanding during each reporting period. Diluted loss per share has been calculated using the weighted-average number of common shares plus the potentially dilutive effect of securities such as outstanding options and warrants. The computation of potential common shares has been performed using the treasury stock method. The warrants and options are antidilutive for all periods presented. When net loss is reported, diluted and basic net loss per share amounts are the same as the impact of potential common shares is antidilutive.
Fair Value Measurements	Fair Value Measurements The Company adopted the provisions of ASC Topic 820, “Fair Value Measurements and Disclosures”, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that may be used to measure fair value: Level 1 — quoted prices in active markets for identical assets or liabilities Level 2 — quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 — inputs that are unobservable (for example cash flow modeling inputs based on assumptions)
Recent Accounting Pronouncements	Recent Accounting Pronouncements From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board or other standard setting bodies that may have an impact on the Company’s accounting and reporting. The Company believes that such recently issued accounting pronouncements and other authoritative guidance for which the effective date is in the future either will not have an impact on its accounting or reporting or that such impact will not be material to its financial position, results of operations, and cash flows when implemented.

SUMMARY OF SIGNIFICANT ACCOUN_3

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION	The stock compensation issued for services during the nine months ended September 30, 2023, were valued on the date of issuance. The following assumptions were used in calculations of the Black-Scholes option pricing models for warrant-based stock compensation issued in the nine months ended September 30, 2023: SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION 2/10/23 2/14/23 3/1/23 3/31/23 4/5/23 4/11/23 Risk-free interest rate 3.93 % 3.77 % 4.01 % 3.60 % 3.30 % 3.54 % Expected life 5 10 10 5 10 5 Expected dividends 0 % 0 % 0 % 0 % 0 % 0 % Expected volatility 123.25 % 123.26 % 123.52 % 120.71 % 119.51 % 119.39 % BIOF common stock fair value $ 0.159 $ 0.159 $ 0.177 $ 0.166 $ 0.154 $ 0.145 4/26/23 6/5/23 7/13/23 7/26/23 Risk-free interest rate 3.46 % 3.77 % 3.93 % 3.86 % Expected life 5 7 5 10 Expected dividends 0 % 0 % 0 % 0 % Expected volatility 119.28 % 103.20 % 90.70 % 87.22 % BIOF common stock fair value $ 0.165 $ 0.170 $ 0.160 $ 0.160

PROPERTY AND EQUIPMENT (Tables)

PROPERTY AND EQUIPMENT (Tables)	9 Months Ended
	Sep. 30, 2023
Property, Plant and Equipment [Abstract]
SCHEDULE OF PROPERTY AND EQUIPMENT	SCHEDULE OF PROPERTY AND EQUIPMENT PROPERTY AND EQUIPMENT Life September 30, 2023 December 31, 2022 Building and Improvements 15 $ 9,370 $ 9,370 Machinery and Equipment 10 $ 791,540 $ 512,450 Furniture and Fixtures 5 $ 13,649 $ 13,649 Computer Equipment 3 $ 11,824 $ 11,824 Property and Equipment, gross $ 826,383 $ 547,293 Less Accumulated Depreciation $ (214,125 ) $ (127,178 ) Property and Equipment $ 612,258 $ 420,115

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
SCHEDULE OF NOTES PAYABLE	A summary of all debts indicated in the Notes above is as follows: SCHEDULE OF NOTES PAYABLE Notes Payable September 30, 2023 December 31, 2022 Short Term Convertible Note – Related Party, including interest $ 371,908 $ 0 Short Term Chapter 11 Settlement $ 0 $ 50,000 Long Term Notes Payable after capital investment, incl interest $ 276,944 $ 0 Long Term Notes Payable from future revenue — Related Party $ 1,700,630 $ 1,700,630 Long Term Notes Payable from future revenue — Other $ 120,000 $ 120,000 Long Term Note Payable from future profits — Related Party $ 820,932 $ 820,932 Long Term Note Payable from future profits — Other $ 96,570 $ 96,570 TOTAL NOTES $ 3,386,984 $ 2,788,132

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET	The Company recognized the following related to leases in its Consolidated Balance Sheet: SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET PERIOD ENDED September 30, 2023 December 31, 2022 Right of Use Lease Liabilities Current portion 101,905 95,172 Long-term portion 8,793 85,983 TOTAL 110,698 181,155
SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS	As of September 30, 2023, the total future minimum lease payments in respect of leased premises are as follows: SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS YEAR ENDED MINIMUM DUE 2023 24,715 2024 85,983 2025 0 TOTAL $ 110,698

ORGANIZATION (Details Narrative

ORGANIZATION (Details Narrative)	9 Months Ended
	Sep. 30, 2023
Product Information [Line Items]
Renewable fuel description	This Program provides monetary incentives to companies that produce renewable transportation fuel, and establishes Renewable Identification Numbers (RINs) or credits for each gallon of renewable transportation fuel produced in the United States, and breaks down those fuels into different D-codes depending on the source of the renewable fuel. D3 is the code for renewable ethanol that comes from cellulosic materials. The EPA’s final D3 RIN volume mandates for cellulosic biofuel include 840 million gallons for 2023, 1.09 billion gallons for 2024, and 1.38 billion gallons for 2025 (the D3 mandate). This mandate has increased every year and is statutorily mandated to increase in the future and become a larger portion of the full renewable fuels mandate, if and when cellulosic biofuels can be produced profitably in larger and larger quantities. The RFS mandate for 2023 calls for 20.94 billion gallons of total renewable fuel, 15 billion from conventional biofuels (corn ethanol) and 5.94 billion from advanced biofuels, including cellulosic biofuels. The “blend wall” (or upper limit to the amount of ethanol that can be blended into U.S. gasoline and automobile performance and comply with the Clean Air Act) of limiting ethanol content in gasoline to 10%, limits the total amount of ethanol consumed in the United States. Recent proposals have make 15% blending available year around in some states. The value of the D3 RIN fluctuates, but as of this filing, it is approximately $3.53 per gallon of ethanol. For comparison, the D6 RIN for corn ethanol is $0.79. To profit from these incentives, the Company plans to apply for these D3 RIN credits as it brings its first plant into commercial operation.
Cost of Goods and Service, Product and Service Benchmark [Member] | Product Concentration Risk [Member] | Vertimass Technology [Member]
Product Information [Line Items]
Dscription of Production	the Company is reviewing whether to start executing on SAF production on a 10 million gallon per year level, and then add the first two steps on to it in a later phase when CTS is fully commercialized. The Company intends to build commercial CTS and ethanol facilities on the front-end to produce cellulosic SAF and generate the large D7 RIN and other government credits

GOING CONCERN (Details Narrativ

GOING CONCERN (Details Narrative) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Accumulated losses	$ 55,331,869	$ 52,781,586

SCHEDULE OF BLACK-SCHOLES OPTIO

SCHEDULE OF BLACK-SCHOLES OPTION PRICING MODELS FOR WARRANT-BASED STOCK COMPENSATION (Details) - Warrant [Member]	9 Months Ended
	Sep. 30, 2023 $ / shares
Issuance Date 2/10/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.93%
Expected life	5 years
Expected dividends	0%
Expected volatility	123.25%
BIOF common stock fair value	$ 0.159
Issuance Date 2/14/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.77%
Expected life	10 years
Expected dividends	0%
Expected volatility	123.26%
BIOF common stock fair value	$ 0.159
Issuance Date 3/1/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	4.01%
Expected life	10 years
Expected dividends	0%
Expected volatility	123.52%
BIOF common stock fair value	$ 0.177
Issuance Date 3/31/2023 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.60%
Expected life	5 years
Expected dividends	0%
Expected volatility	120.71%
BIOF common stock fair value	$ 0.166
Issuance Date 4/5/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.30%
Expected life	10 years
Expected dividends	0%
Expected volatility	119.51%
BIOF common stock fair value	$ 0.154
Issuance Date 4/11/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.54%
Expected life	5 years
Expected dividends	0%
Expected volatility	119.39%
BIOF common stock fair value	$ 0.145
Issuance Date 4/26/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.46%
Expected life	5 years
Expected dividends	0%
Expected volatility	119.28%
BIOF common stock fair value	$ 0.165
Issuance Date 6/5/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.77%
Expected life	7 years
Expected dividends	0%
Expected volatility	103.20%
BIOF common stock fair value	$ 0.170
Issuance Date 7/13/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.93%
Expected life	5 years
Expected dividends	0%
Expected volatility	90.70%
BIOF common stock fair value	$ 0.160
Issuance Date 7/26/23 [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Risk-free interest rate	3.86%
Expected life	10 years
Expected dividends	0%
Expected volatility	87.22%
BIOF common stock fair value	$ 0.160

SUMMARY OF SIGNIFICANT ACCOUN_4

SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Patents	$ 247,854		$ 247,854		$ 222,109
Research and development expenses	$ 293,674	$ 404,157	$ 1,741,318	$ 2,070,789
Minimum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	5 years		5 years
Maximum [Member]
Property, Plant and Equipment [Line Items]
Property and equipment, estimated useful life	10 years		10 years

SCHEDULE OF PROPERTY AND EQUIPM

SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 826,383	$ 547,293
Less Accumulated Depreciation	(214,125)	(127,178)
Property and Equipment	612,258	420,115
Building Improvements [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 9,370	9,370
Estimated Useful Lives	15 years
Machinery and Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 791,540	512,450
Estimated Useful Lives	10 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 13,649	13,649
Estimated Useful Lives	5 years
Computer Equipment [Member]
Property, Plant and Equipment [Line Items]
Property and Equipment, gross	$ 11,824	$ 11,824
Estimated Useful Lives	3 years

PROPERTY AND EQUIPMENT (Details

PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Property, Plant and Equipment [Line Items]
Depreciation	$ 89,526
Purchase value	826,383	$ 547,293
Pilot Plant [Member]
Property, Plant and Equipment [Line Items]
Purchase of machinery	285,538
Machinery [Member]
Property, Plant and Equipment [Line Items]
Disposal of machinery	3,500
Purchase value	6,448
Accumulated depreciation	2,579
Loss on disposal of assets	$ 369

PATENTS (Details Narrative)

PATENTS (Details Narrative) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Finite-Lived Patents, Gross	$ 247,854	$ 222,109

SCHEDULE OF NOTES PAYABLE (Deta

SCHEDULE OF NOTES PAYABLE (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Debt Disclosure [Abstract]
Short Term Convertible Note – Related Party, including interest	$ 371,908	$ 0
Short Term Chapter 11 Settlement	0	50,000
Long Term Notes Payable after capital investment, incl interest	276,944	0
Long Term Notes Payable from future revenue — Related Party	1,700,630	1,700,630
Long Term Notes Payable from future revenue — Other	120,000	120,000
Long Term Note Payable from future profits — Related Party	820,932	820,932
Long Term Note Payable from future profits — Other	96,570	96,570
TOTAL NOTES	$ 3,386,984	$ 2,788,132

DEBT (Details Narrative)

DEBT (Details Narrative)

1 Months Ended

Aug. 10, 2023 USD ($) shares

May 15, 2018 USD ($) shares

Feb. 28, 2018 USD ($) shares

Jul. 31, 2023 USD ($) $ / shares shares

Jun. 30, 2023 USD ($) $ / shares shares

Apr. 30, 2023 USD ($) $ / shares shares

Jan. 31, 2023 USD ($) $ / shares shares

May 31, 2018 USD ($)

Feb. 28, 2018 USD ($) shares

Nov. 30, 2017 USD ($) shares

Jul. 31, 2016 USD ($)

Sep. 30, 2023 USD ($)

Dec. 31, 2022 USD ($)

Mar. 27, 2019 USD ($)

Mar. 26, 2019 USD ($)

Jun. 30, 2018 USD ($)

Debt Instrument [Line Items]

TOTAL NOTES

$ 3,386,984

$ 2,788,132

Notes payable, noncurrent

$ 20,000

$ 32,000

Due out of long term future revenue

2,738,132

Due related to long term notes payable capital investment

275,000

Notes payable amount to be discharged

2,417,502

Due to related parties

969,482

Notes Payable, Other Payables [Member] | AMG Energy Group [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 96,570

Debt interest rate

6%

Renegotiated notes, description

The Company renegotiated this note during its Chapter 11 proceedings, and as per the Plan Confirmation, now the $96,570 is to be paid with no interest out of the same 50% of the future net profits of the Company as the notes mentioned above, if any, or discharged to the extent unpaid five years after September 18, 2019

Renegotiated amount

$ 96,570

Business acquisition, percentage

49%

Edmund Burke [Member] | Convertible Debt [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 50,000

$ 25,000

$ 150,000

Debt instrument, term

5 years

Warrant, reason for issuance, description

accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 50,000 every 12 months instead of interest, with a minimum of 50,000 warrants

accrued warrants, with a strike price of 15 cents and an expiration of 5 years, at the rate of 100,000 every 6 months instead of interest. It may convert into common stock at $0.13/share at the option of the holder for a total of 1,153,846 shares

Edmund Burke [Member] | Convertible Debt [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

192,308

1,153,846

Convertible, conversion price per share | $ / shares

$ 0.13

$ 0.13

Chris Kneppers [Member] | Convertible Debt One [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 50,000

Debt interest rate

10%

10%

Debt instrument, description

The Note is convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a 5-year expiration, for a total of 333,333 shares and warrants

The Note is convertible, at the option of the lender, into common shares of the Company at 15 cents per share, plus a warrant with a strike price of 25 cents per share and a 5-year expiration, for a total of 333,333 shares and warrants

Debt instrument, term

5 years

5 years

Chris Kneppers [Member] | Convertible Debt Two [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 100,000

Chris Kneppers [Member] | Convertible Debt Two [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

769,231

Convertible, conversion price per share | $ / shares

$ 0.13

Chris Kneppers [Member] | Convertible Debt [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 250,000

Chris Kneppers [Member] | Convertible Debt [Member] | Common Stock [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

1,923,077

Convertible, conversion price per share | $ / shares

$ 0.13

Chris Kneppers [Member] | Convertible Debt One [Member] | Warrant [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

333,333

333,333

Related Party [Member]

Debt Instrument [Line Items]

Due to related parties

849,482

Related Party [Member] | AMG Energy Group [Member]

Debt Instrument [Line Items]

Debt interest rate

6%

Renegotiated notes, description

The renegotiated amounts, as per the Plan Confirmation are all to be paid from 50% of the future net profits and discharged to the extent unpaid five years after the Plan effective date of September 18, 2019.

Mark Koch [Member] | AMG Energy Group [Member]

Debt Instrument [Line Items]

Renegotiated amount

$ 240,990

Animated Family Films [Member] | AMG Energy Group [Member]

Debt Instrument [Line Items]

Renegotiated amount

579,942

Steven Dunkle CTWC Wellington Asset Holdings [Member] | AMG Energy Group [Member]

Debt Instrument [Line Items]

Renegotiated amount

$ 1,500,000

Steven Sadaka [Member] | Loans Payable [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 100,000

$ 100,000

Debt instrument maturity date

May 01, 2018

Amount to be paid out of future gross revenues

$ 100,000

Steven Sadaka [Member] | Loans Payable [Member] | Inducement Shares [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

2,000,000

Conversion of convertible securities, value

$ 84,000

Christopher Jemapete [Member] | Loans Payable [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 50,000

Debt interest rate

5%

Debt instrument maturity date

May 16, 2019

Amount to be paid out of future gross revenues

$ 50,315.07

Accrued interest, value

$ 315

Christopher Jemapete [Member] | Loans Payable [Member] | Inducement Shares [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

1,250,000

Conversion of convertible securities, value

$ 36,250

Pamela Jemapete [Member] | Loans Payable [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 50,000

Debt interest rate

5%

Debt instrument maturity date

May 16, 2019

Amount to be paid out of future gross revenues

$ 50,315.07

Accrued interest, value

$ 315

Pamela Jemapete [Member] | Loans Payable [Member] | Inducement Shares [Member]

Debt Instrument [Line Items]

Shares, conversion of convertible securities | shares

1,250,000

Conversion of convertible securities, value

$ 36,250

Lucas Hoppel [Member] | Convertible Debt [Member]

Debt Instrument [Line Items]

Debt instrument principal amount

$ 165,000

$ 165,000

$ 143,000

Debt interest rate

8%

8%

8%

Shares, conversion of convertible securities | shares

500,000

500,000

Debt instrument maturity date

Sep. 21, 2018

May 30, 2018

Conversion of convertible securities, value

$ 14,500

$ 39,500

Original issue discount

$ 15,000

$ 15,000

$ 43,000

Debt instrument conversion discount rate, percentage

40

35

Debt instrument principal payments

$ 40,000

TOTAL NOTES

$ 100,000

$ 100,000

$ 100,000

Percentage of future gross revenue

5%

5%

Other Related Party [Member]

Debt Instrument [Line Items]

Due to related parties

$ 120,000

STOCKHOLDERS_ EQUITY (Details N

STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)	3 Months Ended						9 Months Ended
	Sep. 30, 2023	Jun. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Dec. 31, 2022
Equity [Abstract]
Capital units, authorized	1,010,000,000						1,010,000,000
Common stock, shares authorized	1,000,000,000						1,000,000,000	1,000,000,000
Common stock, par value	$ 0.001						$ 0.001	$ 0.001
Preferred stock, shares authorized	10,000,000						10,000,000	10,000,000
Preferred stock, par value	$ 0.001						$ 0.001	$ 0.001
Common stock, shares issued	302,750,963						302,750,963	289,941,623
Common stock, shares outstanding	302,750,963						302,750,963	289,941,623
Preferred stock, shares Issued	0						0	0
Number of shares issued for services, shares							174,191
Number of shares issued for services, value		$ 5,300	$ 24,000	$ 29,150	$ 16,150	$ 71,300	$ 29,300
Warrants issued for services	50,000	314,000		37,333			364,000
Warrants issued for services, value							$ 48,447
Issuance of common stock and warrants for cash through PPM, shares							6,684,998
Issuance of common stock and warrants for cash through PPM	$ 325,000	$ 95,022	582,750	$ 340,000	$ 675,000		$ 1,002,772
Warrants exercised share, shares							5,950,148
Warrants exercised		$ 25,000	$ 72,250				$ 97,250
Number of warrants expired							2,067,999
Unvested options expired							7,050,000
Unvested options expired							125,000
Number of stock options vested, shares		2,000,000	2,385,000	825,000	800,000	10,560,000	4,385,000
Number of stock options vested, value							$ 637,028
Number of shares unvested	17,150,000						17,150,000
Options issued and unvested value							$ 2,835,613

SCHEDULE OF LEASE CONSOLIDATED

SCHEDULE OF LEASE CONSOLIDATED BALANCE SHEET (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Current portion	$ 101,905	$ 95,172
Long-term portion	8,793	85,983
TOTAL	$ 110,698	$ 181,155

SCHEDULE OF FUTURE MINIMUM LEAS

SCHEDULE OF FUTURE MINIMUM LEASE PAYMENTS (Details)	Sep. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2023	$ 24,715
2024	85,983
2025	0
TOTAL	$ 110,698

COMMITMENTS AND CONTINGENCIES_2

COMMITMENTS AND CONTINGENCIES (Details Narrative)		9 Months Ended
	Sep. 01, 2020 USD ($) a	Sep. 30, 2023 USD ($) a	Sep. 30, 2022 USD ($)
Property, Plant and Equipment [Line Items]
Annual rent		$ 84,100
Percentage of increase in rent per year		3%
Operating costs		$ 3,600
Acres | a	18.2	167.6
Lease cost	$ 6,370	$ 24,721
Lease renewal term	5 years	5 years
Rent expense		$ 183,537	$ 106,631
Office and Laboratory Space [Member]
Property, Plant and Equipment [Line Items]
Lease extension period		This had been extended for one year until October 31, 2022, and was further extended for two more years until October 31, 2024
Percentage of increase in rent per year		3%
Lease expense		$ 102,950

SUBSEQUENT EVENTS (Details Narr

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	1 Months Ended	3 Months Ended			9 Months Ended
	Nov. 07, 2023	Sep. 30, 2023	Jun. 30, 2023	Sep. 30, 2022	Sep. 30, 2023
Subsequent Event [Line Items]
Warrants issued for services, shares		50,000	314,000	37,333	364,000
Warrants issued for services		$ 5,813	$ 42,634	$ 5,317
Subsequent Event [Member]
Subsequent Event [Line Items]
Warrants issued for services, shares	350,000
Warrants issued for services	$ 29,991
Subsequent Event [Member] | Related Party [Member]
Subsequent Event [Line Items]
Convertible note	$ 15,000